Furthermore, patients with sarcopenia frequently exhibit insulin resistance, which can impair cognitive function through various mechanisms, including damaging synaptic integrity, increasing Aβ deposition, and promoting tau protein phosphorylation (Kellar and Craft, 2020). The gene discussed is MAPT; the disease is Insulin resistance.